Published in Cancer Weekly, February 2nd, 2010
"Of these, 114 patients underwent TACE as first-line therapy and were followed until July 2007. At the time of resection, the mean tumor size was 4.8 +/- 2.9 cm, and 96 (84.2%) patients had a single tumor. Single nodular recurrence was observed in 53 (46.5%) patients. The mean...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.